We remain bearish on Schneider National as profitability lags, valuation stretches, and EPS growth seems unlikely. Read more ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer application for approval.

Study results unveiled at ASCO show combining Enhertu with Perjeta can significantly delay tumor growth versus a regimen that ...

Bitcoin trades near $109,000 with institutional interest growing as Coinbase sees massive outflow while analysts predict ...

Bitcoin could fall out of its bullish channel, possibly testing support at $100,000, though the broader outlook remains ...

However, China’s sluggish economic data and Moody’s downgrade of U.S ... resting just above its 50-EMA at $61.75 and testing the rising trendline from the May lows. Price action has stalled ...

Enterprise workflow management platform ServiceNow on Wednesday announced its second AI-related acquisition this year. The terms of the deal weren’t disclosed. Data.World was most recently ...

While this data suggests that validators are favouring the Solana network ... SOL/USDT: 4-Hour Chart To sum up, Solana price is flashing bullish signals, with its bounce from a descending trendline ...

Onchain and technical data now show that the XRP/USD pair is ... The price is retesting the upper trendline of the flag at $2.10, suggesting that a possible breakout is in play.

“And when it comes to his signature issue so far in his second term, tariffs, I mean, my goodness gracious, that trend line is ridiculously awful for Trump.” Earlier in his CNN appearance, Enten ...